SCHEMBL5698552

SCHEMBL5698552

O=C(C(O)=Cc1ccccc1)N(O)NBr

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.44
AKR1C1 Q04828 1/20 0.39
RECQL P46063 1/20 0.39
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
FBP1 P09467 1/20 0.37
TRPM8 Q7Z2W7 2/20 0.36
DHODH Q02127 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629563 0.73 AKR1C3 (0.50) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL8742560 0.69 AKR1C3 (0.54) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL7454012 0.69 AKR1C3 (0.60) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL243721 0.69 AKR1C3 (0.60) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL141612 0.69 AKR1C3 (0.60) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL7179224 0.69 AKR1C1 (0.52) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL29253620 0.68 ALDH1A1 (0.50) AKR1C3AKR1C1RECQLALDH1A1MAPT
SCHEMBL1629856 0.68 AKR1C3 (0.64) AKR1C3AKR1C1RECQLALDH1A1HTT
SCHEMBL14802102 0.68 ALDH1A1 (0.41) AKR1C3AKR1C1ALDH1A1MAPTKDM4E
Methane SCHEMBL1221501 0.68 AKR1C3 (0.58) AKR1C3AKR1C1RECQLALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed